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A 28-year-old woman after anatomic correc-
tion of transposition of the great arteries with 
ventricular septal defect and left ventricular 
outflow tract obstruction at the age of 9 years, 
and aortic valve replacement (AVR) with bio-
prosthesis 21 mm due to aortic regurgitation 
at the age of 22 years reported a dramatic 
deterioration of exercise capacity (from New 
York Heart Association [NYHA] class I to class 
III). Echocardiography demonstrated enlarged 
left ventricle (left ventricular end-diastolic 
volume [LVEDV] = 258 ml), with advanced 
mechanical asynchrony and severely impaired 
systolic function (left ventricular ejection frac-
tion [LVEF] = 22%, whereas two years earlier it 
was 40%) (Figure 1A, Supplementary material, 
Video S1). The mean gradient across the aortic 
valve was 35 mm Hg, and the aortic valve area 
was 0.8 cm2. N-terminal pro-brain natriuretic 
peptide (NT-proBNP) was 2519 pg/ml. A 12-lead 
electrocardiogram showed sinus rhythm with 
left bundle branch block. No further cardiac 
pathologies were found. The heart team decid-
ed that aortic valve replacement would be haz-
ardous because of severe left ventricular systolic 
impairment. Instead, due to left bundle branch 
block (QRS duration, QRSd = 160 ms) (Figure 1A) 
and advanced heart failure the patient was 
referred for cardiac resynchronization therapy 
(CRT). Following the implantation of the CRT 
pacemaker, QRS complexes narrowed to 132 ms 
(Figure 1B), NT-proBNP dropped to 839.5 pg/ml, 
Figure 1. Echocardiography and electrocardiogram; A. Before and B. after cardiac resynchronization therapy
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Supplementary material
Supplementary material is available at https://journals.
viamedica.pl/kardiologia_polska.
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and echocardiographic parameters improved (LVEF 45%, 
LVEDV 190 ml) (Figure 1B; Supplementary material, Video 
S2). A mean gradient across the aortic valve prosthesis was 
60 mm Hg. Consequently, aortic valve replacement (re-AVR) 
with a 21 mm mechanical prosthesis was performed, along 
with the LeCompte maneuver and reconstruction of the 
pulmonary artery with vascular graft. Six months after the 
surgery, NT-proBNP dropped to 272 pg/ml, LVEF raised to 
48%, and LVEDV decreased to 179 ml. Exercise capacity 
was restored (NYHA class I). The patient returned to her 
normal activities, reporting a great improvement in her 
quality of life.
Implantation of the CRT pacemaker as a bridge to sur-
gery is an innovative approach. So far, only one report has 
been published on the use of CRT as a bridge to surgery 
in patients with aortic valve stenosis and left ventricular 
dyssynchrony [1]. Our case is the first to describe such 
treatment in a patient with congenital heart disease. Since 
the decision regarding CRT implantation relies mainly on 
the physicians’ experience [2], we believe our case will 
inspire other clinicians to use this approach in different 
groups of patients. 
